RLAY logo

Relay Therapeutics, Inc. (RLAY) Accounts Receivable

Annual Accounts Receivable:

N/A
December 31, 2024

Summary

  • RLAY annual accounts receivable is not available.

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

RLAY Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$82.65M
RLAY annual accounts receivable is currently at an all-time high

3-Year Low

$0.00
RLAY annual accounts receivable is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RLAY previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 25, 2026
RLAY next annual earnings announcement is scheduled for Feb 25, 2026

OtherRLAYbalance sheet metrics

Annual Accounts Payable

$14.10M
RLAY annual accounts payable is $14.10 million

Annual Total Assets

$871.30M
RLAY annual total assets is $871.30 million

Annual Total Liabilities

$93.50M
RLAY annual total liabilities is $93.50 million

Annual Cash & Cash Equivalents

$124.29M
RLAY annual cash & cash equivalents is $124.29 million

Quarterly Accounts Receivable:

N/A
September 30, 2025

Summary

  • RLAY quarterly accounts receivable is not available.

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

RLAY Quarterly Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

All-Time High

$82.65M
RLAY quarterly accounts receivable is currently at an all-time high

3-Year Low

$0.00
RLAY quarterly accounts receivable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
RLAY previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 25, 2026
RLAY next earnings announcement is scheduled for Feb 25, 2026

OtherRLAYbalance sheet metrics

Quarterly Accounts Payable

$2.75M
RLAY quarterly accounts payable is $2.75 million

Quarterly Total Assets

$670.00M
RLAY quarterly total assets is $670.00 million

Quarterly Total Liabilities

$62.29M
RLAY quarterly total liabilities is $62.29 million

Quarterly Cash & Cash Equivalents

$596.43M
RLAY quarterly cash & cash equivalents is $596.43 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

RLAY Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year--
3Y3 Years--
5Y5 Years--

RLAY Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year
5Y5-Year
All-TimeAll-Time

RLAY Accounts Receivable History

DateAnnualQuarterly
Dec 2023
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2023
-
$211.00K(+170.5%)
Jun 2023
-
$78.00K(-98.5%)
Mar 2023
-
$5.23M(+0.2%)
Dec 2022
$5.22M
$5.22M(+2.0%)
Sep 2022
-
$5.12M(+1.3%)
Jun 2022
-
$5.05M(+2.1%)
DateAnnualQuarterly
Mar 2022
-
$4.95M(+0.1%)
Dec 2021
$4.94M(-94.0%)
$4.94M(-2.3%)
Sep 2021
-
$5.05M(+13.0%)
Jun 2021
-
$4.47M(-48.0%)
Mar 2021
-
$8.61M(-89.6%)
Dec 2020
$82.65M(>+9900.0%)
$82.65M(>+9900.0%)
Dec 2019
$0.00
$0.00

FAQ

  • What is the all-time high annual accounts receivable for Relay Therapeutics, Inc.?
  • What is the all-time high quarterly accounts receivable for Relay Therapeutics, Inc.?

What is the all-time high annual accounts receivable for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high annual accounts receivable is $82.65M

What is the all-time high quarterly accounts receivable for Relay Therapeutics, Inc.?

Relay Therapeutics, Inc. all-time high quarterly accounts receivable is $82.65M
On this page